CervoMed Inc

CRVONASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

13.5M

on 2026-06-30, from 6.17M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3 of 2024-10-03. Not read yet. S-3 ↗

$50.0M

Leerink Partners, agreement of 2025-05-12. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

11.04M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

3.6 quarters

$24.9M on 2026-06-30 ÷ $7.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-06-18	Public offering	2,500,000	$4.00	$10.0M	424B5 ↗
2026-06-09	Private placement	not read	not read	$10.5M	8-K ↗